Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/25/e8/1a/25e81a34-f526-c0ff-1244-e14282c3cf2f/mza_719636057694412014.jpg/600x600bb.jpg
The Evidence Based Rheumatology Podcast
Michael Putman
100 episodes
1 month ago
A podcast for physicians about evidence based medicine in rheumatology. Each week we'll critique and apply a paper in the medical literature.
Show more...
Medicine
Health & Fitness,
Science,
Nature,
Life Sciences
RSS
All content for The Evidence Based Rheumatology Podcast is the property of Michael Putman and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
A podcast for physicians about evidence based medicine in rheumatology. Each week we'll critique and apply a paper in the medical literature.
Show more...
Medicine
Health & Fitness,
Science,
Nature,
Life Sciences
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/25/e8/1a/25e81a34-f526-c0ff-1244-e14282c3cf2f/mza_719636057694412014.jpg/600x600bb.jpg
E121: Obinutuzumab in SLE-LN
The Evidence Based Rheumatology Podcast
18 minutes
7 months ago
E121: Obinutuzumab in SLE-LN
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965
The Evidence Based Rheumatology Podcast
A podcast for physicians about evidence based medicine in rheumatology. Each week we'll critique and apply a paper in the medical literature.